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Abstract 
Monocytes play an important role in the immune system and are responsible for phagocytizing 
and degrading foreign microorganisms in the body. The isolation of monocytes is important in 
various immunological applications such as in-vitro culture of dendritic cells. We present a 
magnetophoretic-based microfluidic chip for rapid isolation of highly purified, untouched 
monocytes from human blood by a negative selection method. This bioseparation platform 
integrates several unique features into a microfluidic device, including locally engineered 
magnetic field gradients and a continuous flow with a buffer switching scheme to improve the 
performance of the cell separation process. The results indicate high monocyte purity and 
recovery performances at a volumetric flow rate that is nearly an order of magnitude larger 
than comparable microfluidic devices reported in literature. In addition, a comprehensive 2-D 
computational modeling is performed to determine the cell trajectory and trapping length 
within the microfluidic chip. Furthermore, the effects of channel height, substrate thickness, 
cell size, number of beads per cell, and sample flow rate on the cell separation performance are 
studied.  
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1 Introduction 
Human monocytes are involved in innate immune system and are responsible for the host 
defense against pathogenic invaders such as viruses, bacteria, and parasites. They can 
differentiate into different cell types such as macrophages and dendritic cells to provoke and 
regulate an immune response and destroy pathogens or pathogen infected host cells (Yuan et 
al. 2007). The isolation of highly purified monocytes is important in immunological research 
such as in-vitro generation of dendritic cells from peripheral blood and to study infectious 
diseases. Over the past decade, several microfluidic-based concepts have been investigated to 
isolate cells from blood (Nagrath et al. 2007; Qu et al. 2008; Talasaz et al. 2009;  Stott et al. 
2010; Mach and Di Carlo 2010; Hoshino at al. 2011;Moon et al. 2011; Wu et al. 2013; Ozkumur 
et al. 2013; Karabacak et al. 2014). In recent years, several ferromagnetic-based microfluidic 
devices have been developed to isolate circulating tumor cells (CTCs) from human peripheral 
blood (S. Kim et al. 2013; Y.Y. Huang et al. 2015; W. Park et al.  2015). A capture efficiency 
of approximately 90% was demonstrated by spiking CTCs into human peripheral blood. 
However, these devices are generally hampered by complex fabrication processes and low 
volumetric throughputs. For example, the volumetric throughputs in some of these studies were 
limited to 0.48 mL/hr (Stott et al. 2010) and less than 2.5 mL/h (Wu et al. 2013). At these flow 
rates, the time required to isolate monocytes from a 10 mL sample is more than 4 hours. Such 
long processing times make the low-flow rate platforms unsuitable for clinical applications. To 
address some of these issues, we present a magnetophoretic microfluidic device for rapid 
isolation of highly purified, untouched monocytes from human blood by a negative selection 
method. Magnetophoretic separation is a process in which a magnetically labeled bioparticle 
is isolated from a mixture by applying a magnetic field. The process involves the labeling of 
the target bioparticles with antibodies and magnetic beads, followed by separating the tagged 
bioparticles via a magnetic separation device. The antibodies specifically bind to their matching 
antigen on the surface of the bioparticle and functionalized groups on the bead surface. 
Magnetophoretic separation can be implemented by a direct or an indirect method. In the direct 
method, surface-treated magnetic beads are first mixed with a sample containing the target 
bioparticles and incubated for a sufficient amount of time, where the functionalized magnetic 
beads bind to the bioparticles. The labeled bioparticles are then isolated from the solution by 
applying an external magnetic field. In the indirect approach, the target bioparticle is first 
tagged with a primary antibody. Magnetic beads with surface-bound secondary antibodies are 
then added to the mixture and incubated where magnetic beads bind to the primary antibody 
on the surface of the bioparticle. Additionally, the magnetophoretic separation can be either 
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positive or negative. In positive selection, the magnetically labeled target cells are retained in 
the magnetic separation device, while the non-target particles flow through the device. In 
negative selection, however, the unwanted cells are retained and the untouched target cells flow 
through the chip and collected at an outlet of the bioseparation chip. The negative selection 
method is preferred in applications where alteration in functional properties of isolated cells is 
not desired.  
Magnetophoretic separation has proven to be effective for the isolation of various types of 
bioparticles from their native environment (Zborowski et al. 1995). It is significantly faster 
than competing techniques and can isolate the target bioparticles directly from the crude 
samples such as blood, bone marrow, and tissue homogenates. In addition, since the unlabeled 
bioparticles have a very low magnetic susceptibility, the contrast between the labeled and 
unlabeled bioparticles is quite large, resulting in a high selectivity. The magnitude of the 
magnetic flux gradient is an important factor that affects the capture and isolation of magnetic 
particles. Both permanent magnets and electromagnets (Furlani and Sahoo 2006; Shevkoplyas 
et al. 2007) can be used to produce a magnetic flux gradient. However, electromagnets can 
generate a significant ohmic heating that may damage cells and decease cell viability. 
In this paper, a negative selection method is used to isolate highly purified, untouched 
monocytes from human blood using a magnetophoretic-based microfluidic chip. Additionally, 
a two-dimensional computational modeling is performed to optimize the chip design and study 
the effects of channel height, substrate thickness, cell size, number of beads per cell, and sample 
flow rate on cell separation performance.  
2 Materials and Methods 
2.1 Fabrication and Operation of Bioseparation Chip  
A schematic of the microfluidic-based magnetophoretic bioseparation chip is shown in Fig. 1. 
A sample containing mononuclear cells is first mixed and incubated with a cocktail of 
biotinylated monoclonal antibodies to magnetically label non-monocytes. The sample is then 
introduced into the chip, where non-monocytes are depleted by retaining them in the 
microfluidic chip, while the untouched monocytes flow through the chip. A continuous buffer 
flow prevents cells from sticking to the channel wall and also improves cell purity by focusing 
the sample to the center region of the channel. This bioseparation platform incorporates several 
unique features into a microfluidic device, including the use of short- and long-range magnetic 
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field gradients, and a continuous flow with a buffer switching scheme to improve the 
performance of the cell separation process (Darabi and Guo 2013). The direction and 
magnitude of the force on a magnetically-labeled target particle are governed by the gradient 
of the magnetic flux. Thus, in order to achieve an efficient and reproducible magnetophoretic 
separation, the precise control of this parameter in the vicinity of the magnetic particle is 
crucial. In our design, a thin nickel grid is deposited and patterned on a glass substrate to 
precisely control the magnetic field gradients. Since nickel has a much higher permeability 
compared to its surroundings, a strong magnetic field gradient is created at the edges of the 
nickel grid when it is subjected to an external magnetic field. In addition, an array of external 
magnets with opposing poles is placed on the bottom side of the chip. This arrangement creates 
a large, long-range non-uniform magnetic field at the edges and interface of the magnets to 
selectively pulled down magnetically labeled cells from the stream and immobilize them on 
the nickel grids. 
 
Figure 1 Schematic illustration of a monocyte isolation chip. A sample containing untouched 
monocytes and non-target cell-bead complexes are introduced into the chip. The non-target 
cell-bead complexes are selectively pulled down and trapped at the edges of the nickel strips 
while the untouched monocytes flow through the chip to a collection tube.   
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The chip consists of a glass substrate on which a nickel grid is deposited and patterned. The 
overall dimensions of the chip are approximately 25 mm × 75 mm × 1 mm. The chip has a 
fluidic channel height of 100 µm, a nickel width of 10 µm, a nickel spacing of 25 µm, and a 
nickel thickness of 0.2 µm. The fluidic ports were drilled into another glass substrate. The glass 
substrates were then cleaned and bonded using a double-sided polyimide film. More details on 
the chip fabrication and assembly can be found in an earlier publication of the authors (Darabi 
and Guo 2013). The experimental setup consists of a microfluidic chip, a bidirectional 
MilliGAT pump with a MicroLynx controller for the sample, a syringe pump for the buffer, 
and plastic tubing for making fluidic connections between the pumps and the chip. The 
MilliGAT pump is a programmable bidirectional pump which is capable of infusing and 
withdrawing. The fluid withdrawal feature is ideal for microfluidic applications where smaller 
sample volumes are used. To characterize the performance of the device, the chip was secured 
on a microscope stage to view the cell motion and capture within the fluidic channel as shown 
in Fig. 2.  
 
Figure 2 A photograph of the test setup. The insert in the bottom right corner shows a 
micrograph of the micropatterned nickel grid with trapped cells. 
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2.2 Monocyte Isolation Experiments 
In this work, untouched monocytes were isolated by depletion of non-monocytes from human 
blood using a Monocyte Isolation Kit (Life Technologies, Carlsbad, CA). Peripheral blood 
mononuclear cells (MNCs) were first obtained from fresh human blood by the Ficoll-Paque 
PLUS method. Approximately 107 MNCs were transferred to a 1.5-mL Eppendorf tube and 
incubated with 20 µL blocking reagent and 20 µL antibody mix (Life Technologies). To isolate 
pure monocytes from mononuclear cells by negative isolation, an antibody mix containing  
biotinylated mouse IgG antibodies for CD3, CD7, CD16, CD19, CD56, CDw123 and CD235a 
(Life Technologies)  was added to the tube. This antibody mix binds to non-monocytes (i.e T 
cells, B cells, NK cells, dendritic cells, erythrocytes, granulocytes, and macrophages).  The 
sample was mixed well and incubated with gentle rotation at 2-8ºC for 20 minutes. The sample 
was centrifuged at 300g for 8 minutes at 2-8ºC and supernatant was removed. The pellets were 
re-suspended in 900µL cold isolation buffer. 100 µL pre-washed MyOne Dynabeads were 
added to the sample and mixed well by pipetting to attach the antibody-labeled non-target cells 
to the Dynabeads. The sample was incubated for 15 minutes at 2-8ºC with gentle rotation.  
Prior to each monocyte isolation test, the chip and tubing were washed with 10% bleach and 
rinsed with deionized water. It was then soaked with 20% bovine serum albumin (BSA) for 30 
min and rinsed with isolation buffer. Next, the sample was withdrawn into the tubing using the 
bidirectional milliGAT pump and the sample tubing was connected to the sample inlet port. 
The sample containing untouched target monocytes and magnetically-labeled non-monocytes 
was introduced into the chip. The buffer flow rate was set to 5 mL/h using the syringe pump. 
The sample flow rate was varied from 10 mL/hr to 50 mL/hr in 10 mL/hr increments. When 
the sample is introduced into the chip, bead bound cells (i.e. T cells, B cells, NK cells, dendritic 
cells, granulocytes, and erythrocytes) and free beads are selectively pulled down and trapped 
at the edges of the nickel grid in the magnetic trapping region, while the untouched human 
monocytes flow through the chip and are collected at an outlet port of the chip. Once, the entire 
sample was infused, the buffer flow rate was increased to 20 mL/hr and kept running until the 
monocyte collection tube reached 1 mL. The collected human monocytes can be then used in 
any application such as cell culture, generation of monocyte derived dendritic cells, functional 
assays, molecular studies and flow cytometry. After each test, the bead-bound cells and free 
beads are eluted form the chip and discarded.  
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To obtain monocyte purity and recovery, the isolated monocyte samples and pre-isolation 
samples were individually stained with 10 μL of CD45 FITC/CD14-PE antibody solution (BD 
Biosciences) and analyzed on a flow cytometer.  The pre-isolation isotype control sample was 
stained with a 20 μL IgG1 FITC/IgG1 PE antibody and incubated at room temperature with 
gentle rotation for 30 minutes. The samples were centrifuged at 350 g for 8 minutes and 
supernatants were carefully removed. The pellets were re-suspended in 200 μL isolation buffer 
and analyzed on a FACS Aria (BD Biosciences). Each test was repeated three times and the 
average values and standard deviations of monocyte purity and recovery were calculated.  
Figure 3 shows a representative flow cytometric dot plot of the sample before and after 
monocyte isolation. Monocytes are identified as positive for both CD45 FITC/CD14-PE, as 
represented by the Q2 quadrant on the dot plot. Regions Q1, Q3, and Q4 represent non-target 
cell populations. The concentration of the monocytes prior to isolation was 13.6%. After 
isolation, the purity of the monocytes increased to 86.4%. Figure 4 shows percent purity and 
recovery of the monocytes as a function of the sample flow rates. The sample flow rate was 
varied from 10 mL/hr to 50 mL/hr. The results indicate that the cell purity decreases with 
increasing the sample flow rate while the cell recovery increases. This is due to the fact that 
the hydrodynamic force increases with increasing the sample flow rate. Thus, the 
magnetophoretic force is not sufficient enough to pull down and trap magnetically-labeled non-
monocytes with fewer numbers of beads per cell. As a result, some of the non-monocytes flow 
through channel into the collection tube, resulting in lower cell purity. However, as the flow 
rate increases, the likelihood of none-specific monocyte trapping under magnetically-labeled 
non-target cells decreases as well, resulting in a higher recovery performance. 
 
 
This is an author-created, un-copyedited version of an article published in Biomedical Microdevices.  The final 
publication is available online at DOI 10.1007/s10544-016-0105-8 
 
8 
 
 
Before Isolation 
 
After Isolation 
 
Figure 3 Flow cytometric analyses before and after monocyte isolation. Quadrant regions show 
the percentage of cells in each sub-population. Monocytes are identified as positive for both 
CD45 FITC and CD14-PE, as represented by the Q2 quadrant on the dot plot. The 
concentration of the monocytes was 13.6% prior to isolation. After isolation, the purity of the 
monocytes increased to 86.4%.  
 
 
Figure 4 Purity and recovery of isolated monocytes by negative depletion method at various 
sample flow rates. The error bars depict the standard deviation.   
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3 Modeling and Simulation 
3.1 Simulation of Long-range Permanent Magnets  
The AC/DC module in COMSOL Multiphysics was used to simulate magnetic field gradients 
surrounding an array of permanent magnets. The permanent magnets used in this study were 
grade N52 NdFeB magnets (K&J Magnetics) with dimensions of 19 mm × 1.6 mm × 6.35 mm 
and were magnetized through the 6.35 mm dimension. These magnets are made from an alloy 
containing Neodymium, Iron, and Boron. The relative permeability and remanence 
magnetization of the magnets are 1.05, and 1.43 T, respectively (Campbell 1996).  Initially, the 
magnetic field simulations were performed for a single magnet to verify our modeling 
approach. The magnetic flux generated by a permanent magnet is given by 
?⃗? = 𝜇(?⃗? + ?⃗⃗? )      (1) 
where ?⃗?  is the magnetic flux density, ?⃗?  is the magnetic field strength, ?⃗⃗?  is the remanence  
magnetization, and 𝜇 is the magnetic permeability. When the Magnetic Fields with no currents 
is selected in COMSOL, the model solves the magnetic scalar potential, Vm, given by   
𝛻. 𝜇(−∇𝑉𝑚 + 𝑀0⃗⃗ ⃗⃗  ⃗) = 0       (2) 
The magnetic flux density can be then obtained from the magnetic scalar potential using: 
?⃗? = 𝜇(−∇𝑉𝑚 + 𝑀0⃗⃗ ⃗⃗  ⃗)      (3) 
where 𝑀0⃗⃗ ⃗⃗  ⃗ is the initial remanence magnetization. To verify our magnetic field simulations 
results for a single magnet, the magnetic flux at the center of the magnet was compared with 
the technical data reported by K&J magnetics.  The simulated and reported magnetic flux 
density at the surface of the magnet were 0.70 T and 0.69 T, respectively, validating our 
modeling results.  
Once a single magnet was simulated and verified, simulations were performed for an array of 
permanent magnets with opposing poles to obtain long-range magnetic field gradients. The 
number of magnets was varied from 2 to 14. The simulations results revealed that when 8 or 
more magnets were used, the fringing effect at the ends of the array of magnets was minimal 
and the magnitude of the magnetic field was nearly the same at each interface. Normal magnetic 
fluxes at various distances from the surface of the magnets for an array of 10 magnets is shown 
in Fig. 5. All dimensions are in mm. The results clearly show that the magnetic flux reaches 
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peak values at the interface between adjacent magnets. In addition, the results show that the 
peak values of the magnetic flux decrease as the distance from the surface of the magnets 
increases. In the rest of the simulation study, the magnetic flux density along the channel was 
assumed to be a repetition of the magnetic flux between two peaks. 
 
Figure 5 Normal magnetic flux density for an array of 10 magnets at various distances from 
the surface of the magnets 
3.2 Simulation of Short-range Micro-scale Gradients  
One of the key features of our device is the use of short-range magnetic field gradients, 
generated by an array of micro-patterned nickel grids on the bottom substrate (Hale and Darabi 
2014). The purpose of the nickel grid is to create high microscale magnetic field gradients to 
trap and immobilize magnetic particles, and enable uniform distribution of the captured cells. 
Figure 6 depicts the effect of micro-patterned nickel grid on the short-range magnetic field 
gradients. The width and thickness of each strip were 10 µm and 0.2 µm, respectively. The gap 
between the strips was 25 µm. Periodic boundary conditions were applied to the left and right 
sides of the computational domain. A uniform magnetic flux boundary condition is applied to 
the bottom surface. The simulation results show that the magnetic field strength increases by 
up to eight-fold at the edges of the nickel grids. 
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Figure 6 Magnetic field simulations above a pair of nickel strips. The magnetic flux density 
increases by up to eight-fold at the edges of the nickel grids.  
 
3.3 Simulation of Particle Trajectory and Motion  
A 2-D model was developed in a Cartesian coordinates to simulate the particle trajectory and 
trapping along the fluidic channel. Figure 7 shows a schematic diagram of the computational 
domain. This 2-D representation is adequate due to a large aspect ratio of the width of the 
microfluidic channel to its height (which was 100:1 in this study).  Only a single pair of nickel 
strips was included in the model. The presence of a large number of neighboring nickel strips 
was simulated by imposing periodic boundary conditions on the left and right sides of the 
model. COMSOL Multiphysics was used to perform two-dimensional numerical simulations 
of the magnetic fields above the nickel strips. The values of the magnetic field at discrete points 
within the model were then exported into MATLAB to compute the magnetic field gradient at 
discrete points within the model. The positions of these nodes and their corresponding magnetic 
field values were arranged and interpolated to create position and magnetic field gradient 
matrices.  
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Figure 7 A schematic diagram of the 2-D computational domain.  The thickness of the nickel 
film is not drawn to scale. w and g represent the nickel strips width and gap.   
It is assumed that the particle under examination is spherical.  Brownian forces and particle-to-
particle interactions are assumed negligible.  In the presence of an external magnetic field, the 
motion of a magnetophoretic particle is mainly governed by the magnetophoretic force, 𝐹 𝑚, the 
hydrodynamic drag force, 𝐹 𝑑, and to lesser extend the net gravitational force, 𝐹 𝑔. It should be 
noted that the forces due to gravity and buoyancy are included for the sake of generalization of 
the model. However, they are approximately an order of magnitude smaller than the other 
forces.  The motion of a magnetic particle flowing through a fluidic channel can be predicted 
by Newton’s second law 
𝑚𝑝
𝑑?⃗? 𝑝
𝑑𝑡
= 𝐹 𝑚 + 𝐹 𝑔 + 𝐹 𝑑     (4) 
where 𝑚𝑝 and ?⃗? 𝑝 are the mass and velocity of the particle, respectively. The magnetophoretic 
force acting on a single magnetic bead is given by (Purcell 1985) 
𝐹 𝑚 = (?⃗⃗? 𝑏 ∙ ∇)?⃗?        (5) 
where ?⃗?  is the applied magnetic field, ?⃗⃗? 𝑏 is the magnetic moment of the magnetic bead, 
expressed by  
?⃗⃗? 𝑏 = 𝑉𝑏?⃗⃗? 𝑏                                        (6) 
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where ?⃗⃗? 𝑏 is the volumetric magnetization of the magnetic bead. For superparamagnetic beads 
used in this study, the hysteresis effect is negligible and magnetization curves overlap when 
magnetic field is increased or decreased (Darabi and Guo 2013). In addition, as depicted in Fig. 
3, the magnetic flux density generated within the fluidic channel is greater than 0.4 T. Thus, 
the magnetization of superparamagnetic beads is saturated and the magnetic force acting on the 
particle can be found from: 
𝐹 𝑚 = 𝑉𝑏?⃗⃗? 𝑠𝑎𝑡 ∙ ∇?⃗?        (7) 
where ?⃗⃗? 𝑠𝑎𝑡 is the volumetric saturation magnetization of the superparamagnetic beads. As 
discussed in the previous section, the magnetic field produced by an array of permanent 
magnets can be considerably complicated. Also, to implement an effective cell separation, 
several micron-sized magnetic beads must bind to the surface of the cell. Thus, a particle 
traveling through the fluidic channel is not spherical in shape. In addition, since the magnetic 
beads are randomly attached to the surface of the cell, the direction of the magnetic force on 
each bead is slightly different depending on the location of the beads. However, in many 
magnetophoretic-based cell separations, the target cell is much larger than a single magnetic 
bead. For example, the average size of mononuclear cells (lymphocytes and monocytes) varies 
between 8-12 µm while a 1 µm bead size was used in this study. Also, the distance between 
the beads on a cell is much smaller than the distance between the cell and the permanent 
magnets. Thus, the labeled cell-beads complex can be considered as a sphere with an effective 
radius estimated from (Safaryk and Safarykova 1997), 
R𝑝 = (
3
4
𝑉𝑃/𝜋)
1/3
      (8) 
where  R𝑝 is the effective radius of the cell-beads complex and 𝑉𝑝 is the total volume of the 
cell and magnetic beads. The total magnetophoretic force acting on a magnetically-labeled cell 
can be estimated from,   
𝐹 𝑚 = 𝑁𝑉𝑏?⃗⃗? 𝑠𝑎𝑡 ∙ ∇?⃗?        (9) 
where N is the number magnetic beads bound to a cell. The hydrodynamic drag force refers to 
a force acting opposite to the direction of the movement. At low Reynold numbers, the drag 
force is mainly affected by the relative motion of the particle with respect to its surrounding 
medium and is expressed by Stokes’ Law, 
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𝐹 𝑑 = 6πR𝑝η(?⃗? 𝑓 − ?⃗? 𝑝)                                                (10) 
where ?⃗? 𝑝 is the particle velocity, 𝑅𝑝 is the particle radius,  ?⃗? 𝑓 is the fluid velocity, and 𝜂 is the 
fluid viscosity. The net gravitational force is defined here as the difference between the 
downward gravitational and upward buoyancy forces and is given by 
𝐹 𝑔 = (𝜌𝑝 − 𝜌𝑓)𝑣𝑝𝑔                                                 (11) 
where 𝜌𝑝 is the particle density, 𝜌𝑓 is the fluid density, and 𝑣𝑝 is the particle volume. Since the 
density of the particle is larger than the density of the fluid, the particle experiences a net 
gravitational force toward the bottom of the channel, which may affect the particle trapping 
especially at low flow rates. 
Force matrices were generated for the magnetophoretic force (Eq. 9), the hydrodynamic drag 
force (Eq. 10), and the net gravitation force (Eq. 11) within the microfluidic chip. The 
components of these three matrices were summed to generate matrices for the total force in 
both the axial (x) and the normal (y) directions.  These force matrices were then used to 
calculate the axial and normal components of each cell’s velocity relative to the fluid as 
follows: 
In the x-direction 
𝑚𝑝
𝑑𝑉𝑝,𝑥
𝑑𝑡
= 𝐹𝑑,𝑥 + 𝐹𝑚,𝑥                                                      (12) 
In the y-direction 
𝑚𝑝
𝑑𝑉𝑝,𝑦
𝑑𝑡
= 𝐹𝑑,𝑦 + 𝐹𝑚,𝑦 + 𝐹𝑔                                       (13) 
The velocity profile for a fully developed laminar flow in microfluidic channels is defined as: 







h
y
h
y
hw
Q
V f 16      (14)                                                        
where 𝑄 is the volumetric flow rate, ℎ is the channel height,  𝑤 is the channel width, and y is 
the height within the channel at which the velocity is calculated. Therefore, the absolute 
velocity of the spherical particles in the microfluidic channel can be calculated as: 
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         






h
y
h
y
hw
Q
VV xpx 16,                              (15) 
                                                      ypy VV ,                                                                    (16) 
where Vx and Vy are the absolute particle velocities in the axial and normal directions. The next 
step after the velocities are obtained is to calculate the position of the particles with respect to 
time.  This is done by assuming that the particles move at a constant velocity for a discreet 
amount of time. By defining the particle position, ),( iii yxS , the initial particle position at the 
channel entrance is set to (0,0). As the time is incremented, a new position for each particle is 
obtained from the following equations: 
                                    tVxx ixii   11                                   (17) 
                                   tVyy
iyii

 11
                                   (18) 
where x and y refer to the horizontal and vertical position of the particle, and t  is the timestep. 
Next, the forces acting on the particle at the new position were obtained and the velocities of 
the particle were calculated. By repeating these steps, the trajectory of each particle with respect 
to time was determined until it is captured on the bottom channel or it flows through the 
channel. The particle is considered captured when  
𝑦𝑛 = ℎ      (19) 
Once the above condition is met, the trapping length and time are found from 
𝐿 = 𝑥𝑛       (20) 
T = n∆t       (21) 
3.4 Modeling Results  
Since it is not possible to simulate purity and recovery data, a key parameter by which the 
performance of the bioseparation chip was evaluated in this study was the trapping length, 
which refers to a horizontal distance that a particle travels along the separation channel before 
it is trapped on the bottom of the channel. To ensure that most of the magnetically labeled cells 
can be trapped within the microfluidic channel, the trapping length and time were calculated 
for an extreme case where the particles travel along the top surface of the channel. To validate 
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the computational model, a series of experiments were carried out using 1-µm 
superparamagnetic beads and the simulated trapping lengths were compared with the 
experimentally measured trapping lengths. The sample flow rate was varied from 10 mL/h to 
50 mL/h in 10 mL/h increments.  The buffer flow rate was set to 5mL/h during all bead capture 
experiments. Each test was repeated three times and the average values of the trapping length 
of superparamagnetic beads were calculated. The trapping length indicates the farthest distance 
the magnetic beads can travel before being captured.  Figure 8 shows a comparison between 
the experimental and simulation results. It can be seen from these results that a good agreement 
is obtained between the experimental and simulation results. Once validated, the model was 
used to optimize the chip design and to study the effects of geometric and operating parameters 
such as number of magnetic bead per cell, cell size, channel height, substrate thickness, and 
flow rate on the cell trajectory along the microfluidic channel.  
 
 
Figure 8 A comparison between the experimental and simulated trapping length at various 
flow rates 
 
Figure 9 shows the cell trajectory at various numbers of magnetic beads per cell ranging from 
2-10. The channel height was 100 µm, the cell size was 10 µm, the bead size was 1 µm, the 
substrate thickness was 300 µm, and the flow rate was 50 mL/h.  The results indicate that the 
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trapping length decreases with increasing the number of beads per cell. This is due to the fact 
that the magnetic force is proportional to the number of beads. Thus, a larger number of beads 
per cell result in a shorter trapping length. It should be noted that the fluid velocity near the top 
and bottom of the channel is smaller than the average velocity. This is the reason for the initial 
steep decrease in the vertical position of the cell as indicated by the concave region of the 
graphs. In addition, as the cell approaches the bottom of the microfluidic channel, the magnetic 
field gradient increases, resulting in an increase in the slope of the graph near the bottom of the 
channel. The effect of cell size on the particle trajectory is depicted in Fig. 10. Three different 
cell sizes of 8 µm, 10 µm, and 12 µm were simulated. The channel height was 100 µm, the 
bead size was 1 µm, the number of beads per cell was 6, the substrate thickness was 300 µm, 
and the flow rate was 50 mL/h. The simulation results indicate that the trapping length increases 
as the cell size increases from 8 µm to 12 µm. As shown in Eq. 8, the magnitude of the drag 
force is linearly proportional to the cell radius (i.e. the drag force is greater on larger particles). 
Thus, for the same magnetic force, larger cells move further downstream before being trapped, 
resulting in a larger tapping length.  
 
Figure 9 Cell trajectories along the microfluidic channel at various numbers of beads per cell.  
The cell size, bead size, channel height, substrate thickness, and flow rate were 10 µm, 1 µm, 
100 µm, 300 µm, and 50 mL/h. 
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Figure 10 Cell trajectories at various cell sizes. The number of beads, bead size, channel height, 
substrate thickness, and flow rate were 6, 1 µm, 100 µm, 300 µm, and 50 mL/h. 
 
Figure 11 depicts the effect of the channel height on the trapping length. As seen there, the 
trapping length increases with increasing the channel height. This is because for a given sample 
flow rate, the magnitude of the magnetic field gradient decreases with increasing the channel 
height. Thus, the magnetic force is lower, which causes the cells to move further downstream 
before it is trapped. Figure 12 shows the effect of the substrate thickness on the trapping length. 
The results show that the trapping length increases with increasing the substrate thickness. This 
trend is similar to the channel height effect. Since the magnitude of the magnetic field gradient 
decreases with increasing the substrate thickness, the magnetic force decreases as well, 
resulting in an increase in the trapping length. The trajectory of the cell along the channel at 
various flow rates is shown in Fig. 13. The number of beads, bead size, cell size, channel height, 
and substrate thickness were 6, 1 µm, 10 µm, 100 µm, and 300 µm. As the flow rate increases, 
the particle velocity increases as well in the x-direction. Therefore, depending on the magnetic 
force strength, the cell travels farther downstream or even may not be captured as the flow rate 
increases. 
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Figure 11 Cell trajectories at various channel heights. The number of bead, bead size, cell size, 
substrate thickness, and flow rate were 6, 1 µm, 10 µm, 300 µm, and 50 mL/h. 
 
Figure 12 Cell trajectories at various substrate thicknesses. The number of beads, bead size, 
cell size, channel height, and flow rate were 6, 1 µm, 10 µm, 100 µm, and 50 mL/h. 
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Figure 13 Cell trajectories at various flow rates. The number of beads, bead size, cell size, 
channel height, and substrate thickness were 6, 1 µm, 10 µm, 100 µm, and 300 µm. 
 
4 Conclusions 
In this study, a microfluidic platform was successfully demonstrated for continuous isolation 
of highly purified human monocytes. The results indicate that a cell purity of nearly 90% and 
a recovery of 87% can be obtained at a flow rate of 50 mL/hr in a single stage separation 
process. Additionally, a computational model was developed to simulate short- and long-range 
magnetic field gradients generated by and array of permanent magnets and micro-pattered 
nickel strips. The magnetic field simulations were then used to optimize the chip design and 
predict the particle motion and trajectory within the microfluidic channel. Furthermore, a 
comprehensive parametric study was conducted to investigate the effects of various geometric 
and operating parameters on the particle trajectory and trapping length. The trapping length 
was found to increase with increasing the cell size, channel height, substrate thickness, flow 
rate, while it decreased with increasing the number of beads per cell. The microfluidic device 
described here has the potential to be integrated into a Lab-on-a-Chip (LOC) system for rapid 
and effective separation of cells and molecules.  
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